![]()
|
|
||||||||
J. Biol. Chem., Vol. 276, Issue 52, 48623-48626, December 28, 2001
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
§,
§,
,
,
,
,
,
,
From the Central infusion of angiotensin IV or its
more stable analogues facilitates memory retention and retrieval in
normal animals and reverses amnesia induced by scopolamine or by
bilateral perforant pathway lesions. These peptides bind with high
affinity and specificity to a novel binding site designated the
angiotensin AT4 receptor. Until now, the
AT4 receptor has eluded molecular characterization. Here we
identify the AT4 receptor, by protein purification and peptide sequencing, to be insulin-regulated aminopeptidase (IRAP). HEK
293T cells transfected with IRAP exhibit typical AT4
receptor binding characteristics; the AT4 receptor ligands,
angiotensin IV and LVV-hemorphin 7, compete for the binding of
[125I]Nle1-angiotensin IV with
IC50 values of 32 and 140 nM, respectively. The
distribution of IRAP and its mRNA in the brain, determined by
immunohistochemistry and hybridization histochemistry, parallels that
of the AT4 receptor determined by radioligand binding. We also show that AT4 receptor ligands
dose-dependently inhibit the catalytic activity of IRAP. We
have therefore demonstrated that the AT4 receptor is IRAP
and propose that AT4 receptor ligands may exert
their effects by inhibiting the catalytic activity of IRAP thereby
extending the half-life of its neuropeptide substrates.
Howard Florey Institute of Experimental
Physiology and Medicine, University of Melbourne and ¶ Ludwig
Institute for Cancer Research and Walter and Eliza Hall Institute,
Royal Melbourne Hospital, Parkville, Victoria 3010, Australia
To whom correspondence should be addressed. Tel.:
61-3-8344-7332; Fax: 61-3-9348-1707; E-mail:
sychai@hfi.unimelb.edu.au.
This article has been cited by other articles:
![]() |
A. Vinh, R. E. Widdop, G. R. Drummond, and T. A. Gaspari Chronic angiotensin IV treatment reverses endothelial dysfunction in ApoE-deficient mice Cardiovasc Res, January 1, 2008; 77(1): 178 - 187. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Goto, A. Hattori, S. Mizutani, and M. Tsujimoto Asparatic Acid 221 Is Critical in the Calcium-induced Modulation of the Enzymatic Activity of Human Aminopeptidase A J. Biol. Chem., December 21, 2007; 282(51): 37074 - 37081. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G. Wallis, M. F. Lankford, and S. R. Keller Vasopressin is a physiological substrate for the insulin-regulated aminopeptidase IRAP Am J Physiol Endocrinol Metab, October 1, 2007; 293(4): E1092 - E1102. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kotlo, S. Shukla, U. Tawar, R. A. Skidgel, and R. S. Danziger Aminopeptidase N reduces basolateral Na+-K+-ATPase in proximal tubule cells Am J Physiol Renal Physiol, October 1, 2007; 293(4): F1047 - F1053. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Maruyama, A. Hattori, Y. Goto, M. Ueda, M. Maeda, H. Fujiwara, and M. Tsujimoto Laeverin/Aminopeptidase Q, a Novel Bestatin-sensitive Leucine Aminopeptidase Belonging to the M1 Family of Aminopeptidases J. Biol. Chem., July 13, 2007; 282(28): 20088 - 20096. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Oliveira, C. M. Costa-Neto, C. R. Nakaie, S. Schreier, S. I. Shimuta, and A. C. M. Paiva The Angiotensin II AT1 Receptor Structure-Activity Correlations in the Light of Rhodopsin Structure Physiol Rev, April 1, 2007; 87(2): 565 - 592. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Rangel, Y. Sun, L. Guzman-Rojas, M. G. Ozawa, J. Sun, R. J. Giordano, C. S. Van Pelt, P. T. Tinkey, R. R. Behringer, R. L. Sidman, et al. Impaired angiogenesis in aminopeptidase N-null mice PNAS, March 13, 2007; 104(11): 4588 - 4593. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Ruster and G. Wolf Renin-Angiotensin-Aldosterone System and Progression of Renal Disease J. Am. Soc. Nephrol., November 1, 2006; 17(11): 2985 - 2991. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Goto, A. Hattori, Y. Ishii, S. Mizutani, and M. Tsujimoto Enzymatic Properties of Human Aminopeptidase A: REGULATION OF ITS ENZYMATIC ACTIVITY BY CALCIUM AND ANGIOTENSIN IV J. Biol. Chem., August 18, 2006; 281(33): 23503 - 23513. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Hunyady and K. J. Catt Pleiotropic AT1 Receptor Signaling Pathways Mediating Physiological and Pathogenic Actions of Angiotensin II Mol. Endocrinol., May 1, 2006; 20(5): 953 - 970. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. C. Li, D. J. Campbell, M. Ohishi, S. Yuan, and J. L. Zhuo AT1 receptor-activated signaling mediates angiotensin IV-induced renal cortical vasoconstriction in rats Am J Physiol Renal Physiol, May 1, 2006; 290(5): F1024 - F1033. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Blume, C. Undeutsch, Y. Zhao, E. Kaschina, J. Culman, and T. Unger ANG III induces expression of inducible transcription factors of AP-1 and Krox families in rat brain Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2005; 289(3): R845 - R850. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-H. Feng, L. Zhou, R. Qiu, and R. Zeng Single Mutations at Asn295 and Leu305 in the Cytoplasmic Half of Transmembrane {alpha}-Helix Domain 7 of the AT1 Receptor Induce Promiscuous Agonist Specificity for Angiotensin II Fragments: A Pseudo-Constitutive Activity Mol. Pharmacol., August 1, 2005; 68(2): 347 - 355. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Esteban, M. Ruperez, E. Sanchez-Lopez, J. Rodriguez-Vita, O. Lorenzo, H. Demaegdt, P. Vanderheyden, J. Egido, and M. Ruiz-Ortega Angiotensin IV Activates the Nuclear Transcription Factor-{kappa}B and Related Proinflammatory Genes in Vascular Smooth Muscle Cells Circ. Res., May 13, 2005; 96(9): 965 - 973. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Diaz-Perales, V. Quesada, L. M. Sanchez, A. P. Ugalde, M. F. Suarez, A. Fueyo, and C. Lopez-Otin Identification of Human Aminopeptidase O, a Novel Metalloprotease with Structural Similarity to Aminopeptidase B and Leukotriene A4 Hydrolase J. Biol. Chem., April 8, 2005; 280(14): 14310 - 14317. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Olson, R. Oeckler, X. Li, L. Du, F. Traganos, X. Zhao, and T. Burke-Wolin Angiotensin II stimulates nitric oxide production in pulmonary artery endothelium via the type 2 receptor Am J Physiol Lung Cell Mol Physiol, September 1, 2004; 287(3): L559 - L568. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Lochard, G. Thibault, D. W. Silversides, R. M. Touyz, and T. L. Reudelhuber Chronic Production of Angiotensin IV in the Brain Leads to Hypertension That Is Reversible With an Angiotensin II AT1 Receptor Antagonist Circ. Res., June 11, 2004; 94(11): 1451 - 1457. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. T. Watson, M. Kanzaki, and J. E. Pessin Regulated Membrane Trafficking of the Insulin-Responsive Glucose Transporter 4 in Adipocytes Endocr. Rev., April 1, 2004; 25(2): 177 - 204. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Tanioka, A. Hattori, S. Masuda, Y. Nomura, H. Nakayama, S. Mizutani, and M. Tsujimoto Human Leukocyte-derived Arginine Aminopeptidase: THE THIRD MEMBER OF THE OXYTOCINASE SUBFAMILY OF AMINOPEPTIDASES J. Biol. Chem., August 22, 2003; 278(34): 32275 - 32283. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Lee, T. Mustafa, S. G. McDowall, F. A. O. Mendelsohn, M. Brennan, R. A. Lew, A. L. Albiston, and S. Y. Chai Structure-Activity Study of LVV-Hemorphin-7: Angiotensin AT4 Receptor Ligand and Inhibitor of Insulin-Regulated Aminopeptidase J. Pharmacol. Exp. Ther., April 1, 2003; 305(1): 205 - 211. [Abstract] [Full Text] |
||||
![]() |
P. Schling and T. Schafer Human Adipose Tissue Cells Keep Tight Control on the Angiotensin II Levels in Their Vicinity J. Biol. Chem., December 6, 2002; 277(50): 48066 - 48075. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. I. Sbodio and N.-W. Chi Identification of a Tankyrase-binding Motif Shared by IRAP, TAB182, and Human TRF1 but Not Mouse TRF1. NuMA CONTAINS THIS RXXPDG MOTIF AND IS A NOVEL TANKYRASE PARTNER J. Biol. Chem., August 23, 2002; 277(35): 31887 - 31892. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. T. Le, P. M. L. Vanderheyden, M. Szaszak, L. Hunyady, and G. Vauquelin Angiotensin IV Is a Potent Agonist for Constitutive Active Human AT1 Receptors. DISTINCT ROLES OF THE N- AND C-TERMINAL RESIDUES OF ANGIOTENSIN II DURING AT1 RECEPTOR ACTIVATION J. Biol. Chem., June 21, 2002; 277(26): 23107 - 23110. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |